Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

November 21, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Chemotherapy Induced Nausea and Vomiting
Interventions
DRUG

Dolasetron mesylate injection

"1.8 mg/kg Dolasetron mesylate injection should be injected intravenously 30±10 min before chemotherapy infusion, with the maximum dose not exceeding 100 mg. It can also be mixed with apple juice or apple-grape juice for oral use, the oral dose is 1.8 mg/kg, the maximum amount is not more than 100 mg, taken orally within 1 h before chemotherapy.~Other antiemetic drugs, except dolasetron, are at the discretion of the subject's supervising physician in accordance with clinical practice."

Trial Locations (1)

Unknown

RECRUITING

Anhui Children's Hospital, Hefei

All Listed Sponsors
lead

Anhui Provincial Children's Hospital

OTHER